Records containing: Monoclonal Gammopathy

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-16
Pre-malignant States to Hematologic Malignancies in Firefighters
CLINICAL_TRIALS study record update · 2026-03-27
A Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
CLINICAL_TRIALS study record update · 2025-06-06
A Single Arm, Multicenter, Phase II, Open-Label Trial to Evaluate Efficacy of Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance
CLINICAL_TRIALS study record update · 2025-04-20
Pilot Study of Oral Rifaximin in Patients With Monoclonal Gammopathy
CLINICAL_TRIALS study record update · 2025-04-09
Epidemiological Characteristics Associated With Precursor Lesions of Multiple Myeloma Using Serum M Protein Screening: a Multi-center, Prospective Cohort Study.
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2024-07-09
Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.
CLINICAL_TRIALS study record update · 2023-08-18
A Pilot Study of Dendritic Cell DKK1 Vaccine for Patients With Monoclonal Gammopathy and Stable or Smoldering Myeloma
CLINICAL_TRIALS study record update · 2020-08-26
Frequency and Characteristics of Pruritus in Patients With Monoclonal Gammopathy
CLINICAL_TRIALS study record update · 2020-05-11
A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early
CLINICAL_TRIALS study record update · 2014-01-06
Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy